{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T16:32:06Z","timestamp":1722875526925},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00120-006-1178-4","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T15:16:55Z","timestamp":1158160615000},"page":"1283-1288","source":"Crossref","is-referenced-by-count":7,"title":["Intravesikale Therapie des Overactive-bladder-Syndroms"],"prefix":"10.1007","volume":"45","author":[{"given":"A.","family":"Haferkamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1178_CR1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"Apostolidis","year":"2005","unstructured":"Apostolidis A, Popat R, Yiangou Y et al. (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977\u2013982","journal-title":"J Urol"},{"key":"1178_CR2","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0022-5347(17)41304-8","volume":"141","author":"Brendler","year":"1989","unstructured":"Brendler CB, Radebaugh LC, Mohler JL (1989) Topical oxybutynin chloride for relaxation of dysfunctional bladders. J Urol 141: 1350\u20131352","journal-title":"J Urol"},{"key":"1178_CR3","first-page":"532","volume":"160","author":"Buyse","year":"1998","unstructured":"Buyse G, Waldeck K, Verpoorten C et al. (1998) Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol 160: 532\u2013534","journal-title":"J Urol"},{"key":"1178_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","volume":"55","author":"Chapple","year":"2000","unstructured":"Chapple CR (2000) Muscarinic antagonists in the treatment of overactive bladder. Urology 55 [Suppl 5A]: 33\u201346","journal-title":"Urology"},{"key":"1178_CR5","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/01.ju.0000049903.60057.4b","volume":"169","author":"De","year":"2003","unstructured":"De Wachter S, Wyndaele JJ (2003) Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol 169: 1892\u20131895","journal-title":"J Urol"},{"key":"1178_CR6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eururo.2004.01.016","volume":"46","author":"Dinis","year":"2004","unstructured":"Dinis P, Silva J, Ribeiro MJ et al. (2004) Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: a pilot study. Eur Urol 46: 88\u201393","journal-title":"Eur Urol"},{"key":"1178_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2008-1026333","volume":"51","author":"Enzelsberger","year":"1991","unstructured":"Enzelsberger H, Schatten C, Kurz C (1991) Comparison of emepronium bromide with intravesical administration of lidocaine gel in women with urge incontinence. Geburtshilfe Frauenheilkd 51: 54\u201357","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"1178_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1471-0528.1995.tb10885.x","volume":"102","author":"Enzelsberger","year":"1995","unstructured":"Enzelsberger H, Helmer H, Kurz CH (1995) Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomised trial. Br J Obstet Gynaecol 102: 929\u2013930","journal-title":"Br J Obstet Gynaecol"},{"key":"1178_CR9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11934-005-0037-y","volume":"6","author":"Evans","year":"2005","unstructured":"Evans RJ (2005) Intravesical therapy for overactive bladder. Curr Urol Rep 6: 429\u2013433","journal-title":"Curr Urol Rep"},{"key":"1178_CR10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0140-6736(92)91186-C","volume":"339","author":"Fowler","year":"1992","unstructured":"Fowler CJ, Jewkes D, McDonald WI et al. (1992) Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339: 1239","journal-title":"Lancet"},{"key":"1178_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(99)00498-7","volume":"55","author":"Fowler","year":"2000","unstructured":"Fowler CJ (2000) Intravesical treatment of overactive bladder. Urology 55 [Suppl 5A]: 60\u201364","journal-title":"Urology"},{"key":"1178_CR12","first-page":"486","volume":"48","author":"Fr","year":"1998","unstructured":"Fr\u00f6hlich G, Burmeister S, Wiedemann A, Bulitta M (1998) Intravesikale Instillation von trospiumchlorid, Oxybutynin und Verapamil zur Relaxation des Harnblasen-Detrusors. Arzneim Forsch Drug Res 48: 486\u2013491","journal-title":"Arzneim Forsch Drug Res"},{"key":"1178_CR13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-2008-1026539","volume":"48","author":"Gassner","year":"1988","unstructured":"Gassner K, Briel RC (1988) Effectiveness of intravesical administration of lidocaine gel in females with urge and urge incontinence. Geburthilfe Frauenheilkd 48: 562\u2013566","journal-title":"Geburthilfe Frauenheilkd"},{"key":"1178_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/01443610500443477","volume":"26","author":"Guerrero","year":"2006","unstructured":"Guerrero K, Emery S, Owen L, Rowlands M (2006) Intravesical oxybutynin: practicalities of clinical use. J Obstet Gynaecol 26: 141\u2013143","journal-title":"J Obstet Gynaecol"},{"key":"1178_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","volume":"24","author":"Kessler","year":"2005","unstructured":"Kessler TM, Danuser H, Schumacher M et al. (2005) Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 24: 231\u2013236","journal-title":"Neurourol Urodyn"},{"key":"1178_CR16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1464-410X.2005.05458.x","volume":"95","author":"Kuo","year":"2005","unstructured":"Kuo HC (2005) Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusoroveractivity refractory to anticholinergics. BJU Int 95: 1023\u20131027","journal-title":"BJU Int"},{"key":"1178_CR17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(17)36663-6","volume":"148","author":"Massad","year":"1992","unstructured":"Massad CA, Kogan BA, Trigo-Rocha FE (1992) The pharmacokinetics of intravesical and oral oxybutynin chloride. J Urol 148: 595\u2013597","journal-title":"J Urol"},{"key":"1178_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1590\/S1677-55382004000100012","volume":"30","author":"Palma","year":"2004","unstructured":"Palma PC, Thiel M, Riccetto CL et al. (2004) Resiniferatoxin for detrusor instability refractory to anticholinergics. Int Braz J Urol 30: 53\u201358","journal-title":"Int Braz J Urol"},{"key":"1178_CR19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"Popat","year":"2005","unstructured":"Popat R, Apostolidis A, Kalsi V et al. (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174: 984\u2013989","journal-title":"J Urol"},{"key":"1178_CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2005.01.036","volume":"66","author":"Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T et al. (2005) Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 66: 82\u201387","journal-title":"Urology"},{"key":"1178_CR21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"163","author":"Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 163: 692\u2013697","journal-title":"J Urol"},{"key":"1178_CR22","first-page":"861","volume":"86","author":"Soontrapa","year":"2003","unstructured":"Soontrapa S, Ruksakul W, Nonthasood B, Tappayuthpijarn P (2003) The efficacy of Thai capsaicin in management of overactive bladder and hypersensitive bladder. J Med Assoc Thai 86: 861\u2013867","journal-title":"J Med Assoc Thai"},{"key":"1178_CR23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/(SICI)1520-6777(1999)18:5<447::AID-NAU6>3.0.CO;2-Q","volume":"18","author":"Walter","year":"1999","unstructured":"Walter P, Grosse J, Bihr AM et al. (1999) Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study. Neurourol Urodyn 18: 447\u2013453","journal-title":"Neurourol Urodyn"},{"key":"1178_CR24","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","volume":"192","author":"Werner","year":"2005","unstructured":"Werner M, Schmid DM, Schussler B (2005) Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 192: 1735\u20131740","journal-title":"Am J Obstet Gynecol"},{"key":"1178_CR25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0022-5347(05)67355-7","volume":"164","author":"Yokoyama","year":"2000","unstructured":"Yokoyama O, Komatsu K, Kodama K et al. (2000) Diagnostic value of intravesical lidocaine for overactive bladder. J Urol 164: 340\u2013343","journal-title":"J Urol"},{"key":"1178_CR26","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0022-5347(05)64261-9","volume":"168","author":"Yoshimura","year":"2002","unstructured":"Yoshimura N, Chancellor MB (2002) Current and future pharmacological treatment of overactive bladder. J Urol 168: 1897\u20131913","journal-title":"J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-006-1178-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-006-1178-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-006-1178-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:58:41Z","timestamp":1558609121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-006-1178-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1007\/s00120-006-1178-4","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}